Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Direct oral anticoagulants in patients with severe inherited thrombophilia: a single-center cohort study.

International journal of hematology - 1 Feb 2021

Zuk Joanna, Papuga-Szela Elzbieta, Zareba Lech, Undas Anetta

Abstract excerpt

We investigated the safety and efficacy of direct oral anticoagulants (DOACs) in patients with venous thromboembolism (VTE) associated with severe inherited thrombophilia. In this single-center cohort study, we enrolled 56 consecutive VTE patients with severe inherited thrombophilia, defined as the presence of antithrombin (n = 18), protein C (n = 12) and protein S (n = 12) deficiencies, homozygous Factor V...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Oral
Share to Anticoagulants
Share to Follow-Up Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hemorrhage

Share to Prothrombin

Share to Severity of Illness Index

Share to Thrombophilia

Share to Young Adult

Source

Identifiers

PMID: 33040276
DOI: 10.1007/s12185-020-03012-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Direct oral anticoagulants in patients with severe inherited thrombophilia: a single-center cohort study.PMID 33040276Read ↗

Direct Oral Anticoagulants in Patients with Thrombophilia: Challenges in Diagnostic Evaluation and Treatment.Semantic proximity Read ↗

Inherited Thrombophilia: Implications for Prevention and Treatment of Venous ThromboembolismSemantic proximity Read ↗

Safety profile of rivaroxaban in first-time users treated for venous thromboembolism (deep vein thrombosis and pulmonary embolism) in four European countriesSemantic proximity Read ↗

Anticoagulation Therapy for Venous Thromboembolism From Vitamin K Antagonists to Direct Oral Anticoagulants and BeyondSemantic proximity Read ↗

Pharmacogenetics of Bleeding and Thromboembolic Events in Direct Oral Anticoagulant Users.Semantic proximity Read ↗

Advances in understanding pathogenic mechanisms of thrombophilic disorders.Semantic proximity Read ↗

Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.Semantic proximity Read ↗

Update on recognition and management of patients with acquired or inherited hypercoagulability.Semantic proximity Read ↗

Favourable outcome of multisystem venous thrombosis associated with novel SERPINC1 mutation after treated with dabigatran: a case report and literature reviewSemantic proximity Read ↗

Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial.Semantic proximity Read ↗

Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasiaSemantic proximity Read ↗

Inherited risk factors for venous thromboembolism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.